Eli Shani - 03 Mar 2023 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
EVP,Global Marketing&Portfolio
Signature
/s/ Dov Bergwerk as attorney-in-fact for Eli Shani
Issuer symbol
TEVA
Transactions as of
03 Mar 2023
Net transactions value
$0
Form type
4
Filing time
07 Mar 2023, 15:13:03 UTC
Previous filing
02 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TEVA Ordinary Shares Options Exercise +3,173 +13% 28,225 04 Mar 2023 Direct F1, F2
transaction TEVA Ordinary Shares Options Exercise +20,107 +71% 48,332 04 Mar 2023 Direct F1, F2
transaction TEVA Ordinary Shares Options Exercise +5,896 +12% 54,228 05 Mar 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TEVA Restricted Share Units Award $0 +59,760 $0.000000 59,760 03 Mar 2023 Ordinary Shares 59,760 Direct F1, F2, F3
transaction TEVA Restricted Share Units Options Exercise $0 -3,173 -100% $0.000000* 0 04 Mar 2023 Ordinary Shares 3,173 Direct F1, F2, F4
transaction TEVA Restricted Share Units Options Exercise $0 -20,107 -25% $0.000000 60,321 04 Mar 2023 Ordinary Shares 20,107 Direct F1, F2, F5
transaction TEVA Restricted Share Units Options Exercise $0 -5,896 -33% $0.000000 11,794 05 Mar 2023 Ordinary Shares 5,896 Direct F1, F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F3 Restricted share units were granted on March 3, 2023, with 14,940 vesting on each of March 3, 2024, March 3, 2025, March 3, 2026, and March 3, 2027.
F4 Restricted share units were granted on March 4, 2019, with 3,173 vested on each of March 4, 2021, March 4, 2022, and March 4, 2023.
F5 Restricted share units were granted on March 4, 2022, with 20,107 vested on March 4, 2023, and 20,107 vesting on each of March 4, 2024, March 4, 2025 and March 4, 2026.
F6 Restricted share units were granted on March 5, 2021, with 5,896 vested on each of March 5, 2022 and March 5, 2023, 5,896 vesting on March 5, 2024, and 5,898 vesting on March 5, 2025.